News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Genetics Launches Revolutionary Weapon For The War On Cancer


10/19/2005 5:09:26 PM

At the American Society of Hematology meeting today in San Diego, CA, Cancer Genetics, Inc. (CGI) launched a new, highly sensitive, DNA FISH assay to help diagnose and monitor therapy of chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL). This assay is the first "repeat-free" BCR/ABL four color fluorescent in situ hybridization (F-FISH) probe and is CGI’s first product to be introduced into the United States.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES